Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
Deloitte
Chinese Patent Office
Baxter
Harvard Business School
Dow
Citi
Fuji

Generated: November 20, 2018

DrugPatentWatch Database Preview

Hydrocortisone valerate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydrocortisone valerate and what is the scope of hydrocortisone valerate freedom to operate?

Hydrocortisone valerate is the generic ingredient in two branded drugs marketed by G And W Labs Inc, Perrigo New York, Taro, Sun Pharm Inds Inc, and Fougera Pharms, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-five drug master file entries for hydrocortisone valerate. Five suppliers are listed for this compound.

Pharmacology for hydrocortisone valerate
Synonyms for hydrocortisone valerate
(1S,10S,11S,15S,17S,2R,14R)-17-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyl-5-ox otetracyclo[8.7.0.0<2,7>.0<11,15>]heptadec-6-en-14-yl pentanoate
[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] pentanoate
11|A,17,21-Trihydroxypregn-4-ene-3,20-dione 17-valerate
11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 17-valerate
11beta,21-dihydroxy-3,20-dioxopregn-4-en-17-yl pentanoate
57524-89-7
68717P8FUZ
AC-13156
AC1NR05S
AKOS015961188
BC205714
C26H38O6
CAS-57524-89-7
CHEBI:50865
CHEMBL1200562
Cortisol 17-valerate
CTK6D5448
D02288
DSSTox_CID_25633
DSSTox_GSID_45633
DSSTox_RID_81015
DTXSID9045633
EINECS 260-786-8
EN300-51036
FZCHYNWYXKICIO-FZNHGJLXSA-N
HMS2235G11
Hydrocortisone 17-valerate
Hydrocortisone 17-valerate, analytical standard
hydrocortisone pentanoate
Hydrocortisone valerate (USP)
Hydrocortisone valerate [USAN:USP]
Hydrocortisone valerate, United States Pharmacopeia (USP) Reference Standard
Hydrocortisone-17-valerate
MLS000028655
MLS001076102
NCGC00018263-02
NCGC00024016-03
Opera_ID_1123
Pregn-4-ene-3,20-dione, 11,21-dihydroxy-17-((1-oxopentyl)oxy)-, (11beta)-
Pregn-4-ene-3,20-dione,11,21-dihydroxy-17-[(1-oxopentyl)oxy]-, (11b)-
SCHEMBL80603
SMR000058860
ST075195
Tox21_110853
Tox21_110853_1
UNII-68717P8FUZ
Westcort
Westcort (TN)
Z1894
ZINC4213520

US Patents and Regulatory Information for hydrocortisone valerate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms HYDROCORTISONE VALERATE hydrocortisone valerate OINTMENT;TOPICAL 075085-001 Jul 31, 2001 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Taro HYDROCORTISONE VALERATE hydrocortisone valerate CREAM;TOPICAL 075042-001 Aug 25, 1998 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Taro HYDROCORTISONE VALERATE hydrocortisone valerate OINTMENT;TOPICAL 075043-001 Aug 25, 1998 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Perrigo New York HYDROCORTISONE VALERATE hydrocortisone valerate CREAM;TOPICAL 075666-001 May 24, 2000 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds Inc WESTCORT hydrocortisone valerate OINTMENT;TOPICAL 018726-001 Aug 8, 1983 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
Deloitte
Chinese Patent Office
Baxter
Harvard Business School
Dow
Citi
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.